These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22878095)

  • 61. Proximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry.
    Bley H; Krisp C; Schöbel A; Hehner J; Schneider L; Becker M; Stegmann C; Heidenfels E; Nguyen-Dinh V; Schlüter H; Gerold G; Herker E
    J Biol Chem; 2024 May; 300(5):107286. PubMed ID: 38636657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
    Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
    Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle.
    Li Q; Zhang YY; Chiu S; Hu Z; Lan KH; Cha H; Sodroski C; Zhang F; Hsu CS; Thomas E; Liang TJ
    PLoS Pathog; 2014 May; 10(5):e1004163. PubMed ID: 24852294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Virology and cell biology of the hepatitis C virus life cycle: an update.
    Dubuisson J; Cosset FL
    J Hepatol; 2014 Nov; 61(1 Suppl):S3-S13. PubMed ID: 25443344
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of cell polarization on hepatitis C virus entry.
    Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
    J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
    Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA; Wilson JA
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [TBL] [Abstract][Full Text] [Related]  

  • 69. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
    Zhu YZ; Qian XJ; Zhao P; Qi ZT
    World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD81 and hepatitis C virus (HCV) infection.
    Fénéant L; Levy S; Cocquerel L
    Viruses; 2014 Feb; 6(2):535-72. PubMed ID: 24509809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Scavenger receptor class B type I mediates cell entry of hepatitis C virus.
    Jia ZS; Du DW; Lei YF; Wei X; Yin W; Ma L; Lian JQ; Wang PZ; Li D; Zhou YX
    J Int Med Res; 2008; 36(6):1319-25. PubMed ID: 19094442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
    Colpitts CC; Tsai PL; Zeisel MB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.
    Chiang AW; Wu WY; Wang T; Hwang MJ
    PLoS Comput Biol; 2017 Jan; 13(1):e1005368. PubMed ID: 28129350
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
    Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of hepatitis C virus entry on viral tropism.
    Ding Q; von Schaewen M; Ploss A
    Cell Host Microbe; 2014 Nov; 16(5):562-8. PubMed ID: 25525789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
    Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
    J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Building a mechanistic mathematical model of hepatitis C virus entry.
    Kalemera M; Mincheva D; Grove J; Illingworth CJR
    PLoS Comput Biol; 2019 Mar; 15(3):e1006905. PubMed ID: 30883541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of the hepatitis C virus glycoproteins in infection.
    Flint M; McKeating JA
    Rev Med Virol; 2000; 10(2):101-17. PubMed ID: 10713597
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis C virus entry: beyond receptors.
    Meredith LW; Wilson GK; Fletcher NF; McKeating JA
    Rev Med Virol; 2012 May; 22(3):182-93. PubMed ID: 22392805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion.
    Gerold G; Moeller R; Pietschmann T
    Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.